Regenerative Medicine: The New Frontier in Healing with Special Guest Dr. Stuart Kauffman, DO August 15, 2022 Read More »
Immunis Announces FDA Clearance and Clinical Site for Phase 1/2a Clinical Trial Investigating Immune-Mediated Muscle Atrophy August 9, 2022 Read More »
Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio August 8, 2022 Read More »
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO August 4, 2022 Read More »
Global Mesenchymal Stem Cells Market Intelligence Report 2022: Industry to reach $5.84 Billion by 2027 August 3, 2022 Read More »
